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Abstrak
Latar belakang: Evaluasi terhadap pemberian transfusi belum dilakukan secara optimal baik di hulu  
maupun di hilir. Tujuan penelitian ini untuk mengetahui pengaruh waktu penyimpanan terhadap perubahan 
pH, jumlah trombosit, dan fungsi agregasi yang terjadi pada trombosit pada beberapa hari penyimpanan.
Metode: Disain penelitian potong lintang terhadap sample kantong konsentrat trombosit yang yang telah 
lolos skrining infeksi penyakit menular melalui transfusi darah. Pengujian yang dilakukan ialah terhadap 
pH, jumlah trombosit dan fungsi agregasi terhadap sampel pada tiga waktu pengujian pada hari ke-0, ke 
tiga, dan ke lima penyimpanan.
Hasil: Pada 50 sampel kantong konsentrat trombosit didapatkan kenaikan pH pada hari ke tiga 
penyimpanan kantong trombosit yang disertai penurunan pada hari ke lima. Hal serupa ditemui pula 
pada jumlah trombosit. Sementara penurunan fungsi agregasi trombosit ditemukan lebih awal pada hari 
ke tiga penyimpanan dan didapatkan nilai rendah pada hampir semua sampel.
Kesimpulan: Ketiga parameter yaitu pH, jumlah trombosit, dan fungsi agregasi mengalami penurunan 
pada hari kelima. (Health Science Journal of Indonesia;2015;1:48-51).
Kata kunci: thrombocyte, concentrate, pH, agregasi, waktu penyimpanan.
Abstract
Background: Evaluation for platelet transfusion is not optimal for this moment even in upstream at the 
blood center or in downstream at the hospital. The purpose of this study was to determine the effect of 
storage time to changes in pH, platelet count and function that occurs on platelet aggregation during 
different time storage.
Methods: The study design was cross-sectional on selected bags of platelet concentrates that have passed 
the screening for infection transmitted through blood transfusions. The regular assessment in UTDD for 
PC has been done every month by random sampling with three parameters pH, platelets count and volume 
in the bag of blood. The testing for pH, platelet count, and aggregation functions for 50 samples with three 
different test time were conducted on day 0, third day, and fifth day storage.
Results: On 50 bags samples, pH, and number of platelets increased, but the platelet aggregation function 
decreased on the third day of storage. On the fifth day of storage the pH, number of platelets and the 
platelets aggregation function decreased and found the lowest number almost in all samples.
Conclusion: The three parameters: pH, platelet counts, and aggregation functions decreased on the fifth 
day of storage. (Health Science Journal of Indonesia;2015;1:48-51).
Keywords: platelets, pH, aggregation, platelet storage
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Transfusion for medical treatment, the qualified blood 
and blood components must have sufficient blood cells 
which is still alive and keep it functioned optimally 
when it’s being transfused.1 One bag whole blood 
(WB) obtained from a donor consisted of several 
components such as packed red blood cell (PRC), 
Thrombocyte concentrate (TC), and the plasma. 
The TC is a blood component needed by patients who 
suffer from bleeding to prevent and stop bleeding, due to 
thrombocytopenia.1-3 In fact, clinicians in hospitals often 
complain about patients’ non-optimal response after 
being platelet transfusions. According to Lubis study, it 
is found that about 33.3% patients with abnormalities 
of hemato-oncology at Cipto Mangunkusumo General 
Hospital had unsatisfied respond towards the platelet 
transfusions.4 Furthermore, Chunaeni’s study noted 
that the state refractory towards the platelet transfusion 
is more prevalent in patients who get multiple platelet 
transfusions that are processed from pockets WB.5
The quality and quantity of platelets in TC are 
influenced by many things, among others, selection 
of donors, donor blood sampling, processing, storage, 
and distribution that require special treatment.6 
During the storage, changes may occur in platelets 
blood bags as a result of platelets metabolism. 
According to Lo’s study, it is observed that there are 
any changes in pH in the late storage significantly.7
Most of the standards use the amount of platelet 
and pH as a parameter to measure the TC quality.8 
The American Association of Blood Banks (AABB) 
decides the value of pH < 6.2. The European 
Association of Blood Banks (EABB) decides a 
maximum limit of the pH be 7.4 at the end of TC 
storage.9.10 In addition, the expected number of 
platelets is ³ 5,5x1010 per unit for about ³ 90% of tested 
bags according to AABB standart.9
The function of platelets in hemostatic and thrombosis 
has been able to measure and it becomes gold standard 
examination and is widely used in determining platelet 
function; that is the aggregation function tests that use 
classical agonist is adenosine diphosphate (ADP), 
arachidonic acid, adrenaline, collagen or ristocetin.11,12 
This study aimed to identify the changes of the 
aggregation function, pH and amount of platelet during 
the storage which may affect the quality of the TC.
METHODS
This cross-sectional study was carried out at the 
Regional Blood Transfusion Unit (UTTD) Indonesia 
Red Cross Jakarta and Clinical Pathology 
Department, Medical Faculty/Cipto Mangunkusumo 
General Hospital Jakarta. The study held on 28th 
March until 30th May 2013 towards selected 50 
bags of platelet concentrates that have passed the 
screening of Infection Transmitted Through Blood 
Transfusions (IMLTD); that is Hepatitis B, Hepatitis 
C, Syphilis, and HIV. 
The test was carried out on pH, amounts of platelet 
and aggregation functions for all 50 samples with 
three different test times; i.e day zero, third and 
fifth storage. Inclusion criteria e\were the blood 
met the specified requirement from Indonesia Red 
Cross,13 initial blood taking volume (the main bag) 
350 mL, using triple bags, fluent bloodstream while 
tapping, non-reactive of infection result. Meanwhile, 
exclusion criteria were blood from smoker donors, 
women with hormonal contraceptives, people who 
consume drugs a week before the donor, and were 
tapped more than once.
pH examination
The pH examination was carried out on day zero by 
using a pH meter by draining through the hose and 
collecting by the plastic tube about 5 mL volume, TC 
components that are left on the platelet agitator bag, 
they will be kept in an incubator with temperature 
of 22° ± 2° C and taken back for examination on the 
third and fifth day after the storage.
Examination of the platelets amount 
Samples were taken on day zero of the hose bag 
TC components and then inserted into the tube with 
sample number and time checks labels, then the 
platelet concentrate remaining in the bag is kept in 
platelet agitator incubator with temperature of 22° ± 
2° C to be taken back for the same examination on 
the third and fifth day after the storage.
Examination of aggregation functions
The TC was released into the bag about 5 mL tube 
that has been prepared by sticking the labels on the 
tube with the sample number and the retrieval dates. 
The plasma components obtained from the same 
donor were also taken the sample about 10 mL. The 
platelet aggregation examination was carried out 
on available samples by firstly testing the amount 
of platelet, if the results obtained > 350000/uL then 
the sample diluted by Platelet Poor Plasma (PPP) of 
the same sample numbers and when the number of 
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platelets <15000/uL, the aggregation function tests 
could not be done due to the abnormal indication. 
Samples can be processed when the amount of 
platelet was about 150000-350000/uL. The next 
process was done by using aggregators such as ADP 
at a concentration of 1μM, 5μM, 10μM.
The comparing data analysis of platelets, pH, and 
platelet aggregation was conducted by paired T-test 
with normal distribution or by Wilcoxon test with 
the abnormal distribution. Pearson and Spearman 
correlation test were performed to assess the 
relationship between two numerical variables.
This study has passed the ethical clearance from 
Medical Faculty, University of Indonesia Number. 
60/H2.F1/ETHICS/2013.
RESULTS
On 50 bags samples, we found increasing number of 
pH 7.432 about 0.257 on the third day and decreasing 
the number on the fifth day from the storage of 7.238 
± 0.353 pH.  There is also an increasing number of 
platelets 618 about 256 x 109 / unit on the third day 
of storage, and decreasing on the fifth day of storage 
599 about 271 x 109 / unit.
Figure 1: pH and thrombocyte count changes during the storage
The result of platelet aggregation examination 
showed the samples examined on day 0, there were 
10 samples with normal limits aggregation by using 
ADP 10μM while 40 other samples were below the 
normal one or hypo-aggregation, where on the 3rd 
day all samples hypo-aggregation.
Table 1. Thrombocyte aggregation during the storage 
with ADP 10 µM in day 0 and day 3
Criteria
Day 0 Day 3
n % n %
Normal 10 20% 0 0%
Hypoagregation 40 80% 50 100%
DISCUSSION
In this study, we found that the number of pH and 
platelet increased on the third day after the storage. 
On the fifth day, both parameters started declining. 
On the other hand, the platelet aggregation did not 
decreasing on the third day and getting down on the 
fifth day.
On the third day of storage, there was increasing 
number of pH rather than at the beginning or 
two hours after processing the components. The 
increasing in pH usually occurs due to the abundance 
of oxygen into the blood bag so that the pH was 
getting more alkali. Oxygen will be used for aerobe 
platelet metabolism. Platelets can also be metabolized 
using the anaerobe glucose. The results of platelet 
glycolysis are lactic acid that causes damage to the 
membranes of platelets (lysis), so the atmosphere is 
more acid by the end of the storage.14,15
This increasing  was analyzed as a consequence 
of bags of platelets that has greater permeability 
from the pores of bags, this situation brings into 
the exchange of O2 and CO2 in the TC bags which 
causes increasing number of CO2 and decreasing of 
O2, within the cell, there will be glycolysis process 
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that produces lactic acid (C3H6O3) and starts to be 
imbalance of H2CO3/HO3. The increasing number of 
lactic acid on platelet cells will cause damage to the 
platelet membrane and into the lysis of membrane 
and causes into a more alkali pH levels, it is becoming 
the explanation of the increasing number of pH on 
the third day of storage.14,15
The number of platelet shows an increasing number 
based on the storage duration, it can happen since in 
in vitro platelet cells are shorter than the in vivo about 
five days. The cell death process is running through 
apoptotic mechanisms of cell division which begins 
with the platelets in the early phase, in counting the 
number of platelets by the calculation method named 
“flow cytometry” where the counting indicator was 
done by measuring 2 to 4 microns without assessing 
the condition of the platelet itself, and the next phase 
will be followed by decreasing number of the platelet 
cell lysis on the fifth day of storage.11.14 However, 
decreasing of pH on the fifth day of storage does not 
mean that the average 7238 ± 0.8, this shows that the 
platelet did not activate and change the shapes.
On the platelet aggregation examination, on day 0 of 
storage or two hours after treatment, normal platelet 
cell aggregation shows only 20% or 10 of the 50 
samples studied, it may possible because in most 
cases, the samples are examined more than 3 hours 
from the sample preparation. Then, the samples were 
diluted and continued by a process to homogenize the 
movement of platelet concentrate in the cuvette that 
can activate these cells. Another thing that cause this 
is the contamination of cell lysis of erythrocytes or 
leukocytes for both of the cell because inappropriate 
environment will cause the release of ADP and 
activate the trombosit cells.16,17
In conclusion, the optimum time to use “Thrombocyte 
Concentrate” to the patients should be before the 
third day of the storage because there was decreasing 
of pH, number of platelet and platelet aggregation 
function on the fifth day of the storage.
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